查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1644034

医疗保健领域产生人工智慧的全球市场

Generative Artificial Intelligence in Healthcare
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球医疗保健领域生成人工智慧市场规模将达到 170 亿美元

2024 年医疗保健领域生成人工智慧的全球市场规模估计为 27 亿美元，预计到 2030 年将达到 170 亿美元，在 2024-2030 年分析期内的复合年增长率为 36.0%。医疗保健生成式 AI 解决方案是该报告分析的细分市场之一，预计到分析期结束时复合年增长率将达到 34.6%，达到 97 亿美元。预计在分析期间内，医疗保健产生 AI 服务领域的复合年增长率为 38.1%。

美国市场规模估计为 7.044 亿美元，中国市场预计复合年增长率为 34.3%

预计 2024 年美国医疗保健领域的生成人工智慧市场价值将达到 7.044 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 25 亿美元，2024-2030 年分析期间的复合年增长率为 34.3%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 32.7% 和 31.4%。在欧洲，德国的复合年增长率预计为 25.3%。

全球医疗保健市场中的生成人工智慧 - 主要趋势和驱动因素摘要

生成式人工智慧在医疗保健领域具有怎样的变革潜力？

生成式AI透过分析复杂资料集和产生预测模型的能力再形成医疗保健，从而实现诊断、治疗和患者照护的突破。透过利用大量患者资料、医疗记录和影像扫描，人工智慧演算法可以提供准确、及时的见解，从而显着改善临床结果。生成式人工智慧能够根据现有模式创建新资料，这在诊断成像方面特别有用，可以以无与伦比的准确度识别癌症、心臟病和神经系统疾病等疾病。除了诊断之外，该技术还将有助于建模复杂的生物系统，并能够在电脑上模拟疾病进展和治疗效果，减少对昂贵且耗时的物理实验的依赖。个人化医疗已成为生成式人工智慧的主要应用。透过根据每个患者的基因和生活方式特征来客製化治疗方案，人工智慧可以提供最佳治疗效果并将副作用降至最低。此外，该技术还透过模拟罕见和复杂的医疗状况来支持医学教育和培训，使临床医生能够在受控环境中磨练他们的技能。生成式人工智慧的这些变革能力已使其成为未来医疗保健服务的基石。

为什么製药业处于生成式人工智慧应用的前沿？

随着生成式人工智慧加速药物发现和开发，製药业正模式转移。这项技术大大减少了先前将新药推向市场的高昂时间和成本。人工智慧主导的平台透过识别有前景的分子化合物、模拟它们的相互作用并预测其药理特性来简化临床前阶段。透过促进虚拟药物测试和计算预测，生成性人工智慧最大限度地减少了后期失败的可能性，确保了更高的成功率和更快的核准流程。事实证明，人工智慧在药物再利用中所扮演的角色也将改变游戏规则。透过分析现有资料并探索现有药物的新用途，製药公司可以有效解决未满足的医疗需求。此外，生成性人工智慧将透过选择最佳患者群体、确保遵守研究方案以及分析即时资料以识别异常来增强临床试验管理。这些创新不仅提高了药物开发的速度和精确度，而且有助于提高成本效益并促进更重要的治疗方法的更强大的管道。

医疗保健服务提供者如何将生成性人工智慧融入业务中？

医院和医疗保健提供者正在采用生成性人工智慧来提高业务效率、患者照护和资源利用率。人工智慧系统正在彻底改变行政工作流程，从预约安排和计费到资料管理和合规性监控，使医护人员能够专注于直接与病患的互动。将人工智慧与电子健康记录(EHR) 结合，使临床医生能够获得准确、最新的信息，从而做出更快、更明智的决策。远端医疗正在快速成长，部分原因是人工智慧虚拟助理和诊断工具的推动。这些平台透过提供即时洞察和监控能力提高了远端咨询的质量，尤其是在服务不足和农村地区。此外，人工智慧预测分析可以透过预测患者入院趋势和优化人员部署来支援医院资源规划。由生成式人工智慧引导的机器人辅助手术在精确度方面树立了新的标准并缩短了恢復时间。这些进步反映了人工智慧日益融入医疗保健生态系统，确保了医疗保健提供者和患者获得更好的治疗结果。

哪些因素推动了医疗保健市场生成式人工智慧的成长？

医疗保健市场中产生人工智慧的成长受到几个关键因素的推动，例如医疗保健资料量的增加、计算能力的进步以及个人化护理的需求不断增长。製药公司采用人工智慧是重要的催化剂，可以加快药物研发速度并降低成本。此外，远端医疗服务和远端医疗解决方案的扩展正在推动对人工智慧平台的需求，这些平台可以实现无缝、高效的患者管理，尤其是在医疗保健有限的地区。消费者对精准医疗和个人化治疗的期望正在推动医疗保健提供者采用生成性 AI 工具，以提高患者满意度和临床结果。保险公司也开始使用人工智慧进行诈欺侦测、风险评估和个人化保险政策，该技术在医疗保健领域得到更广泛的应用。此外，政府和私人实体正在大力投资人工智慧研究和创新，监管机构也在进行调整以确保合乎道德的部署和互通性。总的来说，这些因素凸显了生成式人工智慧在医疗保健领域的变革性影响及其在塑造全球医疗保健系统未来方面的作用。

部分

组件（解决方案组件、服务组件）、功能（医学影像分析功能、虚拟护理助理功能、机器人辅助AI手术功能、行政流程优化功能）、用途（临床用途、系统用途）、最终用途（临床研究最终用途、医疗中心最终用途、诊断中心最终用途、其他最终用途）

调查企业范例（共27家企业）

  • Amazon Web Services, Inc.
  • Deloitte
  • ELEKS
  • Google Cloud
  • IBM Corporation
  • Insilico Medicine
  • LeewayHertz
  • Microsoft Corporation
  • Nioyatech LLC
  • NVIDIA Corporation

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP31170

Global Generative Artificial Intelligence in Healthcare Market to Reach US$17.0 Billion by 2030

The global market for Generative Artificial Intelligence in Healthcare estimated at US$2.7 Billion in the year 2024, is expected to reach US$17.0 Billion by 2030, growing at a CAGR of 36.0% over the analysis period 2024-2030. Healthcare Generative AI Solutions, one of the segments analyzed in the report, is expected to record a 34.6% CAGR and reach US$9.7 Billion by the end of the analysis period. Growth in the Healthcare Generative AI Services segment is estimated at 38.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$704.4 Million While China is Forecast to Grow at 34.3% CAGR

The Generative Artificial Intelligence in Healthcare market in the U.S. is estimated at US$704.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 34.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 32.7% and 31.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 25.3% CAGR.

Global Generative Artificial Intelligence in Healthcare Market – Key Trends & Drivers Summarized

What Are the Transformative Capabilities of Generative AI in Healthcare?

Generative Artificial Intelligence is reshaping healthcare by leveraging its ability to analyze complex datasets and generate predictive models, enabling breakthroughs in diagnostics, treatment, and patient care. By harnessing vast volumes of patient data, medical records, and imaging scans, AI algorithms can deliver precise and timely insights that significantly enhance clinical outcomes. Generative AI's ability to create new data from existing patterns is particularly valuable in imaging diagnostics, where it identifies diseases such as cancer, heart conditions, and neurological disorders with unparalleled accuracy. Beyond diagnostics, the technology aids in modeling complex biological systems, allowing for the simulation of disease progression and treatment efficacy in silico, reducing the reliance on costly and time-intensive physical experiments. Personalized medicine has emerged as a flagship application of generative AI. By tailoring treatments to individual patients' genetic and lifestyle profiles, AI ensures optimized care with minimal adverse effects. Furthermore, the technology supports medical education and training by simulating rare and complex medical conditions, empowering clinicians to refine their skills in controlled environments. These transformative capabilities of generative AI have established it as a cornerstone of the future of healthcare delivery.

Why Is the Pharmaceutical Sector at the Forefront of Generative AI Adoption?

The pharmaceutical industry is experiencing a paradigm shift as generative AI accelerates drug discovery and development. This technology significantly reduces the traditionally prohibitive time and cost associated with bringing new drugs to market. AI-driven platforms identify promising molecular compounds, simulate their interactions, and predict pharmacological properties, streamlining the preclinical phase. By facilitating virtual drug trials and computational predictions, generative AI minimizes the likelihood of late-stage failures, ensuring higher success rates and faster approval processes. AI's role in drug repurposing has also proven to be a game-changer. By analyzing existing datasets and exploring new applications for established drugs, pharmaceutical companies can address unmet medical needs more efficiently. Furthermore, generative AI enhances clinical trial management by selecting optimal patient cohorts, ensuring adherence to study protocols, and analyzing real-time data to identify anomalies. These innovations not only improve the speed and accuracy of drug development but also contribute to cost-effectiveness, fostering more robust pipelines for critical therapies.

How Are Healthcare Providers Integrating Generative AI Into Operations?

Hospitals and healthcare providers are embracing generative AI to improve operational efficiency, patient care, and resource utilization. AI-powered systems are revolutionizing administrative workflows, from appointment scheduling and billing to data management and compliance monitoring, allowing healthcare staff to focus on direct patient interactions. Integrating AI with electronic health records (EHRs) ensures that clinicians have access to accurate, up-to-date information, enabling faster and more informed decision-making. Telemedicine has witnessed exponential growth, driven in part by AI-enabled virtual assistants and diagnostic tools. These platforms enhance the quality of remote consultations by offering real-time insights and monitoring capabilities, particularly in underserved and rural areas. Additionally, predictive analytics powered by AI supports hospitals in resource planning by forecasting patient admission trends and optimizing staff deployment. Robotic-assisted surgeries, guided by generative AI, are setting new benchmarks for precision and reducing recovery times. Together, these advancements reflect the growing integration of AI into healthcare ecosystems, ensuring improved outcomes for providers and patients alike.

What Factors Are Driving the Growth of the Generative AI in Healthcare Market?

The growth of the Generative Artificial Intelligence in Healthcare market is driven by several key factors, including the increasing volume of healthcare data, advancements in computational power, and the rising demand for personalized care. The adoption of AI by pharmaceutical companies has been a major catalyst, enabling faster drug discovery and reducing costs. Moreover, the expansion of telehealth services and remote care solutions has fueled demand for AI-powered platforms that facilitate seamless and efficient patient management, particularly in areas with limited healthcare access. Consumer expectations for precision medicine and tailored treatments have pushed healthcare providers to adopt generative AI tools that enhance patient satisfaction and clinical outcomes. Insurers are also turning to AI for fraud detection, risk assessment, and personalized policy creation, broadening the technology's application across the healthcare landscape. Additionally, governments and private entities are making significant investments in AI research and innovation, with regulatory bodies adapting to ensure ethical deployment and interoperability. These factors collectively underscore the transformative impact of generative AI on the healthcare sector and its role in shaping the future of global health systems.

SCOPE OF STUDY:

The report analyzes the Generative Artificial Intelligence in Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Solutions Component, Services Component); Function (Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function, Administrative Process Optimization Function); Application (Clinical Application, System Application); End-Use (Clinical Research End-Use, Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 27 Featured) -

  • Amazon Web Services, Inc.
  • Deloitte
  • ELEKS
  • Google Cloud
  • IBM Corporation
  • Insilico Medicine
  • LeewayHertz
  • Microsoft Corporation
  • Nioyatech LLC
  • NVIDIA Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Generative Artificial Intelligence in Healthcare - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Generative AI Spurs Growth in Diagnostics and Personalized Healthcare Solutions
    • Expansion of Predictive Analytics Tools Broadens Addressable Market in Patient Care
    • Increased Demand for Virtual Health Assistants Drives AI Adoption in Telemedicine
    • Generative AI Revolutionizes Drug Discovery and Accelerates Development Timelines
    • Automation of Administrative Workflows Strengthens the Business Case for AI in Healthcare
    • AI-Driven Advances in Medical Imaging Propel Growth in Radiology Applications
    • IoMT Integration Sustains Growth Opportunities for AI in Connected Healthcare Systems
    • AI-Powered Clinical Decision Support Systems Propel Adoption Across Healthcare Facilities
    • Generative AI Addresses Workforce Shortages by Optimizing Healthcare Delivery
    • AI Innovations Enhance Market Potential for Mental Health Solutions
    • AI-Based Simulation Tools Drive Adoption in Medical Training and Education Programs
    • Precision Oncology Gains Momentum with Generative AI-Enabled Targeted Therapies
    • Data Privacy and Security Challenges Influence Market Dynamics and Adoption Rates
    • AI-Enhanced Patient Engagement Models Create New Opportunities in Care Delivery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Generative Artificial Intelligence in Healthcare Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Solutions Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Solutions Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Medical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Medical Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinical Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Clinical Research End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Medical Imaging Analysis Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Medical Imaging Analysis Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Virtual Nursing Assistants Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Virtual Nursing Assistants Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Robot-Assisted AI Surgery Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Robot-Assisted AI Surgery Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Administrative Process Optimization Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Administrative Process Optimization Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Clinical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Clinical Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for System Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for System Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 28: USA Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • JAPAN
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • CHINA
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 52: China Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • EUROPE
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • FRANCE
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 70: France Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: France 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 72: France Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • GERMANY
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 78: Germany Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Germany 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • UNITED KINGDOM
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 94: UK Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: UK 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 118: Rest of World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030

IV. COMPETITION